Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

Yuemei Hu, Ningshao Xia, Yue Huang et al.|Science Bulletin|2023

Cited by 26